Mechanism of androgenic action: effect of specific intracellular inhibitors.
D015065:17-Hydroxycorticosteroids / Q000494:pharmacology*; D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology*; D002369:Castration; D002499:Centrifugation, Density Gradient; D002850:Chromatography, Gel; D002855:Chromatography, Thin Layer; D013196:Dihydrotestosterone / Q000037:antagonists & inhibitors* / Q000378:metabolism; D008297:Male; D009698:Nucleoproteins / Q000378:metabolism; D011278:Pregnanes / Q000494:pharmacology*; D011422:Propionates / Q000037:antagonists & inhibitors; D011467:Prostate / Q000187:drug effects / Q000254:growth & development* / Q000378:metabolism; D011485:Protein Binding / Q000187:drug effects; D051381:Rats; D012728:Sex Chromatin / Q000378:metabolism; D013739:Testosterone / Q000037:antagonists & inhibitors* / Q000378:metabolism; D014316:Tritium
D015065:17-Hydroxycorticosteroids; D000963:Antimetabolites; D009698:Nucleoproteins; D011278:Pregnanes; D011422:Propionates; D013196:Dihydrotestosterone; D014316:Tritium; D013739:Testosterone